TokenPost·

OpenAI Acquires Orchestra Bio to Expand Its Drug Development Tools

2 outlets reporting
Your call?

The startup's software uses AI agents to monitor studies. OpenAI plans to connect research findings with the work needed to advance potential medicines.

Share

Also covered by 1 outlet

More news